Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine. [electronic resource]
Producer: 19950911Description: 238-43 p. digitalISSN:- 0022-3476
- Antibodies, Bacterial -- biosynthesis
- Bordetella pertussis -- immunology
- Diphtheria-Tetanus-Pertussis Vaccine -- adverse effects
- Double-Blind Method
- Enzyme-Linked Immunosorbent Assay
- Follow-Up Studies
- Humans
- Immunization, Secondary
- Infant
- Pertussis Toxin
- Pertussis Vaccine -- adverse effects
- Time Factors
- Vaccines, Synthetic -- adverse effects
- Virulence Factors, Bordetella
- Whooping Cough -- prevention & control
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.